Search
Displaying results 721 to 730 of 758.
Sebastian Borgert
HZI spin-offs at a glance
HZI spin-offs at a glance Scientists at the HZI regularly and successfully transfer their results and technologies into start-ups and spin-offs. Here we present some of the companies. Leopard Biosciences GmbH SORMAS Foundation gGmbH InSCREENeX GmbH MyxoTech…
About HIRI
© Adobe Stock / Christoph Burgstedt Increasing antibiotic resistance, chronic infections and emerging pathogens pose major challenges for the public health system. While the central importance of RNA in regulatory and sensory cell processes has become…
Tuberculosis
Tuberculosis – a silent pandemic © HZI/Manfred Rohde Tuberculosis Tuberculosis is one of the „big three“ infectious diseases, together with AIDS and Malaria. In Europe, tuberculosis is almost forgotten, the times of the “The Lady of the Camellias” and…
Prof Dr Yang Li
Prof Dr Yang Li Research Group Leader +49 511220027-200 E-Mail Yang Li has headed the Department of Computational Biology for Individualised Medicine at the CiiM and the HZI since 2019 and was also appointed Director of the CiiM. The focus of her research…
Prof Dr Anna K. H. Hirsch
Prof Dr Anna K. H. Hirsch Head of Research Group +49 681 98806 2100 E-Mail Anna Hirsch read Natural Sciences with a focus on Chemistry at the University of Cambridge and spent her third year at the Massachusetts Institute of Technology, doing a research…
Prof Dr Josef Penninger
Prof Josef Penninger Scientific Director - Scientific Management +49 531 6181-1000 E-Mail Josef Penninger was born on 5 September 1964 in Gurten, Oberösterreich. After attending medical school in Innsbruck , he started his scientific career at the…